#news #biotech Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases .Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases
badams
Thu, 02/18/2021 – 05:44

from FierceBiotech: Biotech https://ift.tt/3s3GvYP